Exxonmobil Investment Management Trimmed Its Starbucks Com (SBUX) Position; Protagonist Therapeutics (PTGX) Shorts Lowered By 7.56%

Exxonmobil Investment Management Inc decreased Starbucks Corp Com (SBUX) stake by 5.16% reported in 2017Q3 SEC filing. Exxonmobil Investment Management Inc sold 14,356 shares as Starbucks Corp Com (SBUX)’s stock rose 6.99%. The Exxonmobil Investment Management Inc holds 263,677 shares with $14.16M value, down from 278,033 last quarter. Starbucks Corp Com now has $81.53B valuation. The stock decreased 0.49% or $0.28 during the last trading session, reaching $57.3. About 7.15M shares traded. Starbucks Corporation (NASDAQ:SBUX) has risen 12.48% since December 23, 2016 and is uptrending. It has underperformed by 4.22% the S&P500.

Protagonist Therapeutics Incorporated (NASDAQ:PTGX) had a decrease of 7.56% in short interest. PTGX’s SI was 358,500 shares in December as released by FINRA. Its down 7.56% from 387,800 shares previously. With 89,200 avg volume, 4 days are for Protagonist Therapeutics Incorporated (NASDAQ:PTGX)’s short sellers to cover PTGX’s short positions. The SI to Protagonist Therapeutics Incorporated’s float is 5.06%. The stock decreased 0.26% or $0.05 during the last trading session, reaching $19.5. About 120,176 shares traded. Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 0.00% since December 23, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on January, 25. They expect $0.57 earnings per share, up 9.62% or $0.05 from last year’s $0.52 per share. SBUX’s profit will be $810.99 million for 25.13 P/E if the $0.57 EPS becomes a reality. After $0.55 actual earnings per share reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts 3.64% EPS growth.

Since September 7, 2017, it had 0 buys, and 2 sales for $4.70 million activity. $3.47 million worth of Starbucks Corporation (NASDAQ:SBUX) shares were sold by CULVER JOHN. 22,966 shares were sold by ULLMAN MYRON E III, worth $1.23M.

Among 35 analysts covering Starbucks Corporation (NASDAQ:SBUX), 25 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. Starbucks Corporation has $75.0 highest and $52 lowest target. $64.16’s average target is 11.97% above currents $57.3 stock price. Starbucks Corporation had 81 analyst reports since July 28, 2015 according to SRatingsIntel. On Friday, July 28 the stock rating was maintained by Oppenheimer with “Buy”. The rating was maintained by Jefferies on Tuesday, June 13 with “Buy”. The company was downgraded on Friday, July 28 by Guggenheim. BMO Capital Markets maintained Starbucks Corporation (NASDAQ:SBUX) on Friday, November 3 with “Market Perform” rating. BMO Capital Markets maintained it with “Outperform” rating and $66 target in Friday, October 30 report. BMO Capital Markets maintained the shares of SBUX in report on Tuesday, October 3 with “Hold” rating. The firm has “Buy” rating by Cowen & Co given on Tuesday, October 10. UBS maintained the shares of SBUX in report on Friday, October 30 with “Buy” rating. The firm has “Buy” rating by RBC Capital Markets given on Tuesday, June 13. The company was maintained on Wednesday, September 28 by Wedbush.